A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

Researchers from DZNE and Otto von Guericke University Magdeburg have identified individuals with increased risk for dementia ...

In a recent study, lean muscle mass appeared to be a protective factor against the development of Alzheimer's disease.

The research, published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, was led by Lancaster University in collaboration with the University of Southampton, Nottingham Trent ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

Professionals and caregivers alike are invited to join the Alzheimer’s Association Michigan Chapter for its Upper Peninsula Conference Monday. Registration for the event is open now. The Upper ...

Managing dementia in the complex landscape of neurological disorders stands out as a formidable challenge, affecting millions ...

Writing in the journal Nature Neuroscience ... while the figure is thought to be around 7million in the US. Alzheimer's affects around six in 10 people with dementia. Memory problems, thinking and ...